evolcSign inStart free
Menu

Replicon Health

Develops oral drug candidate RH013001 for aging-related degenerative diseases and seeks pharma partners to bring it to market

Espoo, FinlandFounded 2002repliconhealth.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Replicon Health

Replicon Health Oy is a Finnish biotech company developing RH013001, an oral new active substance (D-glyceric acid, DGA). The company describes it as reducing aging-related subclinical inflammation and activating mitochondrial energy metabolism. Its patented formulation is aimed at age-associated degenerative diseases, including neurodegenerative conditions such as Parkinson's and sarcopenia.

The company reports human studies and peer-reviewed publications on the compound, and holds patents covering RH013001 and related molecules. It says it aims to enter markets with a development partner, and it is looking for partners in multimodal therapies based on mitochondrial activation.

Replicon Health was founded in 2002 and is headquartered in Espoo, Finland. Its CEO and CSO is Petteri Hirvonen, and its Medical Director is Risto Kaksonen. R&D studies are conducted in several locations in Finland, and patenting is outsourced to Munich and Virginia.

Product: RH013001, an oral new active substance (D-glyceric acid) in development for aging-related degenerative diseases.

Jobs at Replicon Health

No open positions listed right now.

Leadership

More biotech & pharma companies

  • RNatives

    Develops RNA-based gene-regulating therapies for serious diseases, with research and offices in Kuopio, Finland
    Kuopio, FinlandBiotech & pharmaFounded 2020
    New on Evolc

  • Sartar Therapeutics

    Develops targeted cancer therapies for patients with gastrointestinal stromal tumours and other cancers
    Helsinki, FinlandBiotech & pharmaFounded 2016
    New on Evolc

  • Scaffdex

    Finnish maker of the RegJoint bioresorbable small-joint implant and CellCrown cell culture inserts for clinicians and researchers
    Tampere, FinlandBiotech & pharmaFounded 2006
    New on Evolc

  • SCellex

    Spatial and bulk 3' RNA-seq tools and services for single-cell gene expression research in biotech and life sciences
    Helsinki, FinlandBiotech & pharmaFounded 2018
    New on Evolc

  • SpringDNA

    Environmental DNA sampling and laboratory analysis for biodiversity monitoring and impact assessments
    Helsinki, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc

  • Suomen Lääkekehityskeskus

    State-owned Finnish company that helps university researchers take drug compounds from early discovery to clinical studies
    Turku, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • WordPress
  • jQuery
  • nginx